š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to demonstrate the performance and safety of t...
Status
Completed
Location
The Seventh Medical Center of PLA General Hospital
Start Date
2019-02-28
Trial ID
NCT03710083
Treatments Being Tested
Current continuous glucose monitoring (CGM) devices provide features that a...
Status
Completed
Location
Shanghai Sixth People's Hospital
Start Date
2024-04-18
Trial ID
NCT05941286
The purpose of Phase 3 Group is to evaluate the impact of acetaminophen on ...
Status
Completed
Location
Barbara Davis Center for Diabetes
Start Date
2019-07-29
Trial ID
NCT04020822
Treatments Being Tested
It has been demonstrated by many different researches that for patients to ...
Status
Completed
Location
Kangbuk Samsung hospital
Start Date
2020-04-07
Trial ID
NCT05150041
Treatments Being Tested
The purpose of this study is to demonstrate the performance of the Guardian...
Status
Completed
Location
AMCR Institue
Start Date
2019-06-14
Trial ID
NCT03966911
Treatments Being Tested
The purpose of this study is to characterize the impact of acetaminophen in...
Status
Completed
Location
AMCR Institue
Start Date
2020-05-18
Trial ID
NCT04378114
Treatments Being Tested
The purpose of this study is to collect sensor, insulin, sleep, activity an...
Status
Completed
Location
Arkansas Diabetes and Endocrinology Center
Start Date
2021-04-06
Trial ID
NCT04809285
Assessment of performance (precision and accuracy) of Guardian Sensorā¢ 3 as...
Status
Completed
Location
Elaine Chow
Start Date
2021-03-01
Trial ID
NCT04776811
Treatments Being Tested
Glycemic imbalances are very common in shock patients admitted to intensive...
Status
Recruiting
Location
CHU de Nice
Start Date
2023-09-11
Trial ID
NCT04910841
Treatments Being Tested
Type 1 Diabetes Mellitus (T1DM) is characterized by absolute insulin defici...
Status
Unknown
Location
Post Graduate Institute of Medical Education and Research
Start Date
2023-08-10
Trial ID
NCT05928260